Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

PHASE2RecruitingINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

December 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Connective Tissue DiseasesThrombocytopenia
Interventions
BIOLOGICAL

Telitacicept

subcutaneous telitacicept 160 mg weekly for 24 weeks.

DRUG

Placebo

subcutaneous placebo weekly for 24 weeks.

Trial Locations (23)

230022

RECRUITING

The First Affiliated Hospital of Anhui Medical College, Hefei

Unknown

RECRUITING

The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Hefei

RECRUITING

Beijing Hospital, Beijing

RECRUITING

Peking University People's Hospital, Beijing

RECRUITING

Peking University Third Hospital, Beijing

RECRUITING

First Affiliated Hospital, Sun Yat-Sen University, Guangzhou

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Wuhan Union Hospital, China, Wuhan

RECRUITING

Second Xiangya Hospital of Central South University, Changsha

RECRUITING

Xiangya Hospital of Central South University, Changsha

RECRUITING

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

RECRUITING

First Hospital of China Medical University, Shenyang

RECRUITING

Shandong Provincial Hospital, Jinan

RECRUITING

Changhai Hospital, Shanghai

RECRUITING

RenJi Hospital, Shanghai

RECRUITING

Shanxi Bethune Hospital, Taiyuan

RECRUITING

West China Hospital, Chengdu

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Tianjin

RECRUITING

Tianjin First Central Hospital, Tianjin

RECRUITING

Tianjin Medical University General Hospital, Tianjin

RECRUITING

People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi

RECRUITING

The First People's Hospital of Yunnan, Kunming

All Listed Sponsors
collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)

OTHER

collaborator

Peking University People's Hospital

OTHER

collaborator

Peking University Third Hospital

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Second Xiangya Hospital of Central South University

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

The Affiliated Hospital of Inner Mongolia Medical University

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

Changhai Hospital

OTHER

collaborator

RenJi Hospital

OTHER

collaborator

Shanxi Bethune Hospital

OTHER

collaborator

West China Hospital

OTHER

collaborator

Institute of Hematology & Blood Diseases Hospital, China

OTHER

collaborator

Tianjin First Central Hospital

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

collaborator

People's Hospital of Xinjiang Uygur Autonomous Region

OTHER

collaborator

The First People's Hospital of Yunnan

OTHER

lead

Beijing Hospital

OTHER_GOV